ArticleACS medicinal chemistry letters2019

Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis.

Steven H Spergel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.